Latest filing published 01 Oct 2026 for Rapport Therapeutics, Inc., €231k.
Filing timeline
BuySaleInsider track record
Cheryl Gault: trading record in brief
Cheryl Gault appears in our data through filings on Rapport Therapeutics, Inc. shares, published by SEC (Form 4). Between 3 March 2025 and 30 September 2026, the trades on record add up to 10 filings.
Sales make up the whole of the open-market record (7 sales, €882k). Besides market trades, the filings include 1 share grant and 2 option exercises. Since January 2026: no purchases and 5 sales on the market.
The record was last updated on 1 October 2026 with an open-market sale (€231k) in Rapport Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Cheryl Gault
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,925 shares@ US$33.0364Common StockSEC:0001193125-26-410734:0
- 2,075 shares@ US$33.7556Common StockSEC:0001193125-26-410734:1
- 7,161 shares@ US$28.040156.3% of flowCommon StockSEC:0001193125-26-134684:0
- 2,839 shares@ US$28.55322.7% of flowCommon StockSEC:0001193125-26-134684:1
- 2,014 shares@ US$28.9316.1% of flowCommon StockSEC:0001193125-26-098488:0
- 5,000 shares@ US$1.802.5% of flowCommon StockSEC:0001193125-25-303910:0
- 5,000 shares@ US$1.802.5% of flowCommon StockSEC:0001839046-25-000004:0
- 13,987 shares0Common StockSEC:0000950170-25-033797:0
8 of 8 declarations